Nav: Home

Light and peptides: New method diversifies natural building blocks of life

April 18, 2019

Discovering new biological targets is a critical part of our ongoing battle against diseases. Over the years, scientists have made impressive progress towards the understanding of biological systems, constantly identifying novel targets. The structural diversity of these targets requires a broad range of different therapeutic agents.

"Small synthetic molecules are still key players, but biomolecules such as peptides, proteins and oligonucleotides have become an important area of research," says Professor Jérôme Waser, director of EPFL's Laboratory of Catalysis and Organic Synthesis. Peptides are particularly interesting, with about 140 evaluated in clinical trials in 2015. However, peptides often are not stable in the blood and cannot permeate cells well, both of which diminish their potential use as drugs.

One solution to overcome these difficulties is chemically modifying the natural structure of peptides, a process called "functionalization". In chemistry, a molecule is "functionalized" by adding chemical groups to it, thus endowing it with new functions, capabilities, or properties, such as enhanced stability in the human body. However, functionalization of peptides is difficult, due to their complex structure.

"The main reason is the lack of selectivity when you try to modify a peptide: it contains many positions that react with chemicals, resulting in useless mixtures," explains Waser. "Therefore, methods enabling selective functionalization of a single position in peptides are actively sought-after to access more efficient ant stable peptide-based drugs."

This is what Waser's lab has now achieved, using "EBX reagents" - a class of very reactive organic compounds developed by the group and now commercially available. Using those reagents, the researchers converted the C-terminal carboxylic acid of peptides into a carbon-carbon triple bond - an alkyne (in chemical jargon a "decarboxylative alkynylation"). The alkyne moiety is a very valuable functional group that can be used to further modify the peptides. It has been used extensively in drug discovery, material sciences and chemical biology.

Peptides do not spontaneously react with EBX reagents, so the scientists had to use a catalyst. In order to activate it, the researchers turned to light or, in more technical terms, "photoredox catalysis": visible light is absorbed by the catalyst, which then selectively activates one bond in the reacting molecules. "Using light as a renewable energy source to perform organic reactions allows a temporal and spatial resolution with very mild reaction conditions," says Waser.

The researchers made two innovations: First, they designed novel fine-tuned organic dyes as photoredox catalysts. This was important as light-mediated reactions are based usually on rare, toxic and expensive transition metal catalysts.

Second, the researchers achieved this first "decarboxylative alkynylation" on native peptides. This is an especially attractive one-step transformation of a natural compound into a synthetic derivative as it offers a platform for modifying the physical and chemical properties of the peptide through a single, easy to perform manipulation (all the "ingredients" just need to be mixed up and let to stand in natural light).

The method can be used with almost all amino acids present on the peptides, while maintaining complete selectivity towards the C-terminal position over the peptide side-chains.

With their new method, the scientists were also able to obtain derivatives from the valuable bioactive peptide GRGDNP that blocks cells from attaching to fibronectin, an important process in the vasodilatation of blood vessels, which could be very useful in the study of cardiovascular disease.
-end-
Reference

Marion Garreau, Franck Le Vaillant Jerome Waser. C-Terminal Bioconjugation of Peptides through Photoredox Catalyzed Decarboxylative Alkynylation. Angewandte Chemie 18 April 2019. DOI: 10.1002/anie.201901922

Ecole Polytechnique Fédérale de Lausanne

Related Peptides Articles:

Pigments by design
Researchers have discovered how to tune the optical and electrical properties of a synthetic polymer similar to melanin, a natural pigment that's the primary factor affecting skin color.
Frog slime kills flu virus
Frogs' skins were known to secrete peptides that defend them against bacteria.
Killing flu viruses with help from a frog
Frog mucus is loaded with molecules that kill bacteria and viruses, and researchers are beginning to investigate it as a potential source for new anti-microbial drugs.
A promising strategy to increase activity in antimicrobial peptides
In an article published recently in Plos One, researchers from INRS-Institut Armand-Frappier Research Centre reported a strategy that could lead to the discovery of new cationic antimicrobial peptides (CAMPs) with greatly enhanced antimicrobial properties.
Sequencing poisonous mushrooms to potentially create medicine
A team of Michigan State University scientists has genetically sequenced two species of poisonous mushrooms, discovering that they can theoretically produce billions of compounds through one molecular assembly line.
More Peptides News and Peptides Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Anthropomorphic
Do animals grieve? Do they have language or consciousness? For a long time, scientists resisted the urge to look for human qualities in animals. This hour, TED speakers explore how that is changing. Guests include biological anthropologist Barbara King, dolphin researcher Denise Herzing, primatologist Frans de Waal, and ecologist Carl Safina.
Now Playing: Science for the People

#534 Bacteria are Coming for Your OJ
What makes breakfast, breakfast? Well, according to every movie and TV show we've ever seen, a big glass of orange juice is basically required. But our morning grapefruit might be in danger. Why? Citrus greening, a bacteria carried by a bug, has infected 90% of the citrus groves in Florida. It's coming for your OJ. We'll talk with University of Maryland plant virologist Anne Simon about ways to stop the citrus killer, and with science writer and journalist Maryn McKenna about why throwing antibiotics at the problem is probably not the solution. Related links: A Review of the Citrus Greening...